CRISPR-Cas9-based target validation for p53-reactivating model compounds
Wanzel, M., Vischedyk, J., Gittler, M., Gremke, N., Mernberger, M., Charles, J., Schneikert, J., Bretz, A.C., Nist, A., Stiewe, T.Volume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)61433-8
Date:
July, 2016
File:
PDF, 57 KB
english, 2016